Veeva Continues Rapid Pace of Innovation to Deliver New Levels of
Speed and Compliance in Content Management for Life Sciences
PLEASANTON, Calif.--(BUSINESS WIRE)--
Veeva Systems (NYSE: VEEV) introduced innovative features in its newest
release of Veeva Vault, version 14. The Veeva Vault platform and suite
of enterprise applications empower life sciences companies to streamline
their business processes across an increasingly broad ecosystem of
internal and external stakeholders.
Today, many life sciences companies use a multitude of disconnected,
complex systems to manage critical content. This fragmented approach
leads to process inefficiencies and increased regulatory risk each time
they develop and commercialize a new product.
Veeva counters this approach with Veeva Vault, a cloud-based content
management platform and suite of applications that provide a single
source of truth to reduce complexity and increase business agility.
Veeva Vault not only manages regulated documents, but also tracks
critical information for product development and commercialization
processes. Only Veeva manages this unique combination of documents and
information to provide deeper insight and improve efficiency.
Powerful new capabilities now available in Veeva Vault allow life
sciences companies to:
-
More accurately plan and track documents – Expected Document
Lists provides a comprehensive plan for expected documents that
ensures better accuracy of document planning and tracking for clinical
and commercial content. Gain full visibility into the status of
document collection, planning, and packaging at all times to measure
the completeness of projects. Additionally, share an accurate list of
expected documents at any time with all key stakeholders.
-
Provide better insight – Document Relationship Reports provide
insight into where and how enterprise content is being re-used by
internal and external stakeholders. Save time and money by leveraging
existing content rather than recreating it. Also, quickly and
accurately perform global impact assessments every time a piece of
content changes or needs to change.
-
Simplify secure access for internal and external collaborators
– Dynamic Access Control simplifies security and access administration
to reduce the risk of errors and improve compliance. Make
enterprise-class security easy with a robust, rules-based security
model that automates access to documents based on information about
the document and the user.
-
Improve business processes – Major enhancements are available
across all Veeva Vault applications — including clinical, quality,
regulatory, medical, and commercial — to increase business agility,
speed time-to-market, and better meet regulatory requirements.
“We continue to innovate at a rapid pace to deliver new levels of
enterprise speed and compliance for our customers to improve their
global business processes,” said Jennifer Goldsmith, senior vice
president of Veeva Vault. “Veeva Vault is enabling life sciences
companies to lower the cost, complexity, time, and compliance risk of
developing and bringing new products to market.”
Today, 18 of the top 20 largest pharmaceutical companies use Veeva Vault
applications to streamline their global business processes. One
fast-growing global biopharmaceutical company, Sucampo Pharmaceuticals
(NASDAQ:SCMP), recently standardized on the Veeva Vault platform and
suite of applications to provide a unified foundation for content and
information management. To learn more, read
today’s press release about how Sucampo is eliminating information
and process siloes across functional teams, regions, and partners for
greater speed, agility, and compliance throughout the product lifecycle.
Additional Information
For more on Veeva Vault, visit: veeva.com/vault
Stay
updated on the latest Veeva news on LinkedIn: linkedin.com/company/veeva-systems
Follow
@veevasystems on Twitter: twitter.com/veevasystems
Like
Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva has more than 400 customers, ranging from the
world's largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices in Europe,
Asia, and Latin America. For more information, visit www.veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on Form
10-K for the period ended January 31, 2016. This is available on the
company’s website at veeva.com
under the Investors section and on the SEC’s website at sec.gov. Further
information on potential risks that could affect actual results will be
included in other filings Veeva makes with the SEC from time to time.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160428005593/en/
Source: Veeva Systems Inc.